NEW YORK (GenomeWeb) – Thermo Fisher Scientific today said that its Ion PGM Dx System has been CE-IVD marked for sale in Europe.

The system was developed using Ion Torrent next-generation sequencing technology and was validated using "challenging" germline variants with library kits based on the Ion AmpliSeq technology. The Ion PGM Dx System includes the instrument, GMP reagents, and software controls to establish high-performing next-generation clinical sequencing workflows, Thermo Fisher said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.